TNBC encompasses a heterogeneous group of breast cancers with distinct clinical characteristics, transcriptomic and genomic features, and unique histopathological differences marked by the lack of expression of ER, PR, and HER2 (Borri and Granaglia, 2021). The gene discussed is PGR; the disease is breast carcinoma.